Literature DB >> 8663595

Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes.

S S Martin1, T Haruta, A J Morris, A Klippel, L T Williams, J M Olefsky.   

Abstract

Insulin stimulation of 3T3-L1 adipocytes causes rapid translocation of actin and the GLUT4 glucose transporter to the plasma membrane. Both processes depend on the activity of phosphatidylinositol 3-kinase. Using single cell microinjection, we have transiently expressed a constitutively activated mutant of phosphatidylinositol 3-kinase, p110*, in 3T3-L1 adipocytes. Fluorescent detection of GLUT4 protein and actin within these cells demonstrates that expression of p110* is sufficient to cause translocation of GLUT4 to the plasma membrane and the formation of actin membrane ruffles. These effects are inhibited by wortmannin in the p110*-expressing cells, indicating that the phosphatidylinositol 3-kinase activity of the protein is required. Overexpression of an identical protein containing a point mutation in the kinase domain, p110*Deltakin, was incapable of mediating either action, confirming that neither the microinjection process nor a nonspecific effect of the protein was responsible for the observed effects. These data suggest that although insulin is capable of inducing numerous signaling pathways, the isolated activation of phosphatidylinositol 3-kinase can initiate the signaling cascade leading to both actin rearrangement and GLUT4 translocation in the absence of insulin stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663595     DOI: 10.1074/jbc.271.30.17605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Expression of a prenylation-deficient Rab4 inhibits the GLUT4 translocation induced by active phosphatidylinositol 3-kinase and protein kinase B.

Authors:  M Cormont; N Gautier; K Ilc; Y le Marchand-Brustel
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

2.  Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1.

Authors:  K M Kriauciunas; M G Myers; C R Kahn
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA.

Authors:  Frank Czauderna; Melanie Fechtner; Hüseyin Aygün; Wolfgang Arnold; Anke Klippel; Klaus Giese; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

5.  SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Unconventional myosin Myo1c promotes membrane fusion in a regulated exocytic pathway.

Authors:  Avirup Bose; Stacey Robida; Paul S Furcinitti; Anil Chawla; Kevin Fogarty; Silvia Corvera; Michael P Czech
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 7.  Fluidity of insulin action.

Authors:  Jeffrey S Elmendorf
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

8.  Insulin and dexamethasone induce GLUT4 gene expression in foetal brown adipocytes: synergistic effect through CCAAT/enhancer-binding protein alpha.

Authors:  Rosario Hernandez; Teresa Teruel; Margarita Lorenzo
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

9.  Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin.

Authors:  June Chunqiu Hou; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

10.  Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide.

Authors:  S A Summers; L A Garza; H Zhou; M J Birnbaum
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.